- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/566 - Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagent
Patent holdings for IPC class G01N 33/566
Total number of patents in this class: 2278
10-year publication summary
138
|
192
|
159
|
194
|
151
|
139
|
114
|
110
|
80
|
25
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immatics Biotechnologies GmbH | 1144 |
66 |
The Regents of the University of California | 18943 |
39 |
The Johns Hopkins University | 5377 |
24 |
Centre National de La Recherche Scientifique | 9632 |
22 |
Firmenich Incorporated | 124 |
22 |
University Health Network | 979 |
21 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
20 |
President and Fellows of Harvard College | 5792 |
20 |
The Trustees of the University of Pennsylvania | 4122 |
20 |
Heptares Therapeutics Limited | 225 |
19 |
Vib VZW | 799 |
17 |
Siemens Healthcare Diagnostics Inc. | 1946 |
16 |
Vrije Universiteit Brussel | 482 |
16 |
The General Hospital Corporation | 4517 |
14 |
Becton, Dickinson and Company | 6712 |
13 |
Massachusetts Institute of Technology | 9795 |
13 |
Novartis AG | 11238 |
12 |
The Regents of the University of Michigan | 4409 |
12 |
Mars, Incorporated | 2940 |
11 |
California Institute of Technology | 3884 |
11 |
Other owners | 1870 |